APP and Alzheimer disease: The APP/PS1 mouse line was used to investigate whether chronic administration of A. muciniphila in conjunction with GOS can alleviate the symptoms of AD by regulating SCFAs levels and reducing the number of microglia in the hippocampus and the Aβ burden in the brain.